Savran Technologies
Pre-clinicalSavranTech develops next generation of non-invasive diagnostics for critical conditions in women’s health, by capture and detection of ultra-rare cells.
Founded
2016
Focus
Diagnostics
About
SavranTech develops next generation of non-invasive diagnostics for critical conditions in women’s health, by capture and detection of ultra-rare cells.
Funding History
2Total raised: $3.2M
Seed$3MUndisclosedMay 15, 2020
Grant$200KNational Institutes of Health (NIH)Jun 15, 2018
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile